Multi-strain phage induced clearance of bacterial infections
PLOS Computational Biology · 2025
DOI: 10.1371/journal.pcbi.1012793 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Jacopo Marchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Maryland, College Park, Maryland, United States of America. Hauptthemen laut MEDLINE: Phage Therapy, Bacteriophages, Pseudomonas Infections, Bacterial Infections. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, Simons Foundation.
Abstract (Originalsprache)
Bacteriophage (or ‘phage’ – viruses that infect and kill bacteria) are increasingly considered as a therapeutic alternative to treat antibiotic-resistant bacterial infections. However, bacteria can evolve resistance to phage, presenting a significant challenge to the near- and long-term success of phage therapeutics. Application of mixtures of multiple phages ( i.e. , ‘cocktails’) has been proposed to limit the emergence of phage-resistant bacterial mutants that could lead to therapeutic failure. Here, we combine theory and computational models of in vivo phage therapy to study the efficacy of a phage cocktail, composed of two complementary phages motivated by the example of Pseudomonas aeruginosa facing two phages that exploit different surface receptors, LUZ19v and PAK_P1. As confirmed in a Luria-Delbrück fluctuation test, this motivating example serves as a model for instances where bacteria are extremely unlikely to develop simultaneous resistance mutations against both phages. We then quantify therapeutic outcomes given single- or double-phage treatment models, as a function of phage traits and host immune strength. Building upon prior work showing monophage therapy efficacy in immunocompetent hosts, here we show that phage cocktails comprised of phage targeting independent bacterial receptors can improve treatment outcome in immunocompromised hosts and reduce the chance that pathogens simultaneously evolve resistance against phage combinations. The finding of phage cocktail efficacy is qualitatively robust to differences in virus-bacteria interactions and host immune dynamics. Altogether, the combined use of theory and computational analysis highlights the influence of viral life history traits and receptor complementarity when designing and deploying phage cocktails in immunocompetent and immunocompromised hosts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biology, University of Maryland, College Park, Maryland, United States of America.
- Institut Pasteur, Université Paris Cité, CNRS UMR6047, Bacteriophage Bacterium Host, Paris, France.
- Sorbonne Université, Collége Doctoral, Paris, France.
- Department of Physics, University of Maryland, College Park, Maryland, United States of America.
- University of Maryland Institute for Health Computing, North Bethesda, Maryland, United States of America.
ORCID-Profile: Jacopo Marchi, Joshua S Weitz
Förderung
- NIAID NIH HHS
- National Institutes of Health
- Simons Foundation
Zitieren
APA
Marchi, J., Minh, C. N. N., Debarbieux, L., & Weitz, J. S. (2025). Multi-strain phage induced clearance of bacterial infections. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012793
Vancouver
Marchi J, Minh CNN, Debarbieux L, Weitz JS. Multi-strain phage induced clearance of bacterial infections. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1012793
BibTeX
@article{Marchi2025,
author = {Marchi, Jacopo and Minh, Chau Nguyen Ngoc and Debarbieux, Laurent and Weitz, Joshua S},
title = {Multi-strain phage induced clearance of bacterial infections},
journal = {PLOS Computational Biology},
year = {2025},
doi = {10.1371/journal.pcbi.1012793}
}
EUVIMED